Xtant Medical

Press Release

NewsPress Release

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont. , April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported
Read more

Xtant Medical to Participate in Upcoming Investor Conferences

BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:
Read more

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

Raises 2023 Annual Revenue Guidance to $88 Million - $91 Million BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial
Read more

Xtant Medical Highlights Growing Product Portfolio at NASS 2023

BELGRADE, Mont. , Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products
Read more

Xtant Medical Announces Second Quarter Revenue Growth of 32%

Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million   BELGRADE, Mont. , Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported
Read more